uniQure NV logo

uniQure NV

QURE
Healthcare|Biotechnology|Netherlands
$42.63
-1.85 (-4.16%)
Tangible Book
$0.87

Analyst Estimates

annual
{ "date": [ "202612", "202712", "202812", "202912", "203012" ], "revenue_estimate": [ 23.84, 72.79, 240.31, 354.77, 617.22 ], "ebit_estimate": [ -207.96, -208.32, -129.14, 141.19, 345.84 ], "ebitda_estimate": [ -199.82, -166.12, -62.83, 30.6, 462.45 ], "net_income_estimate": [ -230.24, -227.19, -163.38, -86.08, 423.1 ], "per_share_eps_estimate": [ -3.56, -3.2, -1.86, -0.6, 3.52 ], "eps_nri_estimate": [ -3.63, -3.26, -2.19, -0.6, 3.52 ], "dividend_estimate": [ null, null, null, null, null ], "book_value_per_share_estimate": [ -4.25, -3.27, null, null, null ], "pretax_income_estimate": [ -231.25, -231.15, -171.71, 211.03, 318.58 ], "operating_cash_flow_per_share_estimate": [ -3.61, -2.2, null, null, null ], "roa_estimate": [ null, null, null, null, null ], "roe_estimate": [ 139.54, 64.03, null, null, null ], "gross_margin_estimate": [ 85.5, 89.05, 85.25, 84.65, 83.15 ], "operating_cash_flow_estimate": [ -226.5, -138.04, null, null, null ], "pettm_estimate": [ 0, 0, 0, 0, 12.1 ], "long_term_growth_rate_mean": 13.78, "long_term_revenue_growth_rate_mean": "151.58", "future_per_share_eps_estimate_growth": 17.92, "future_eps_nri_estimate_growth": 13.78, "future_revenue_estimate_growth": 151.58, "future_ebit_estimate_growth": null, "future_ebitda_estimate_growth": 27.25, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": null, "future_pretax_income_estimate_growth": null, "future_book_value_per_share_estimate_growth": null, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": null }
quarterly
{ "date": [ "202606", "202609", "202612", "202703", "202706", "202709", "202712" ], "revenue_estimate": [ 5.47, 5.9, 6.95, 9.05, 3.9, 7.85, 16.3 ], "ebit_estimate": [ -48.63, -56.68, -61.62, -72.84, -63.2, -64.9, -51.6 ], "ebitda_estimate": [ -46.2, -56.54, -64.34, -81.16, null, null, null ], "net_income_estimate": [ -52.39, -60.16, -63.83, -64.3, -64.3, -66, -52.7 ], "per_share_eps_estimate": [ -0.82, -0.92, -1, -0.91, -0.93, -0.95, -0.88 ], "eps_nri_estimate": [ -0.83, -0.94, -1.03, -1.7, -0.88, -0.88, -0.78 ], "dividend_estimate": [ null, null, null, null, null, null, null ], "book_value_per_share_estimate": [ null, null, null, null, null, null, null ], "pretax_income_estimate": [ -51.9, -59.52, -64.6, -64.3, -64.3, -66, -52.7 ], "operating_cash_flow_per_share_estimate": [ null, null, null, null, null, null, null ], "roa_estimate": [ null, null, null, null, null, null, null ], "roe_estimate": [ null, null, null, null, null, null, null ], "gross_margin_estimate": [ null, null, null, null, null, null, null ], "operating_cash_flow_estimate": [ null, null, null, null, null, null, null ], "pettm_estimate": [ 0, 0, 0, 0, null, null, null ], "long_term_growth_rate_mean": 13.78, "long_term_revenue_growth_rate_mean": "151.58", "future_per_share_eps_estimate_growth": 17.92, "future_eps_nri_estimate_growth": 13.78, "future_revenue_estimate_growth": 151.58, "future_ebit_estimate_growth": null, "future_ebitda_estimate_growth": 27.25, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": null, "future_pretax_income_estimate_growth": null, "future_book_value_per_share_estimate_growth": null, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": null }

News

2026-06-29 10:30:25
2026-06-25 16:35:46
2026-06-24 17:00:34
2026-06-24 13:05:03
2026-06-24 02:25:38
2026-06-23 15:35:03
2026-06-22 21:01:32
2026-06-22 20:28:27
2026-06-22 10:50:23
2026-06-19 11:50:28
2026-06-18 18:34:17
2026-06-18 17:30:54
2026-06-18 16:36:13
2026-06-18 14:36:18
2026-06-18 13:06:29
2026-06-17 18:58:20
2026-06-17 17:57:36
2026-06-17 13:36:48
2026-06-17 12:36:14
2026-06-17 11:58:57